Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 25 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000932 | P-body | 5 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0035770 | ribonucleoprotein granule | 3 | 2 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 4 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
GO:0099080 | supramolecular complex | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:1990124 | messenger ribonucleoprotein complex | 3 | 2 |
GO:1990904 | ribonucleoprotein complex | 2 | 2 |
Related structures:
AlphaFold database: Q4QA41
Term | Name | Level | Count |
---|---|---|---|
GO:0006996 | organelle organization | 4 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016043 | cellular component organization | 3 | 2 |
GO:0022607 | cellular component assembly | 4 | 2 |
GO:0033962 | P-body assembly | 7 | 2 |
GO:0034063 | stress granule assembly | 7 | 2 |
GO:0070925 | organelle assembly | 5 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
GO:0140694 | non-membrane-bounded organelle assembly | 6 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0003729 | mRNA binding | 5 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 142 | 144 | PF00675 | 0.607 |
CLV_NRD_NRD_1 | 182 | 184 | PF00675 | 0.599 |
CLV_NRD_NRD_1 | 263 | 265 | PF00675 | 0.580 |
CLV_NRD_NRD_1 | 283 | 285 | PF00675 | 0.436 |
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.324 |
CLV_PCSK_KEX2_1 | 142 | 144 | PF00082 | 0.624 |
CLV_PCSK_KEX2_1 | 182 | 184 | PF00082 | 0.587 |
CLV_PCSK_KEX2_1 | 283 | 285 | PF00082 | 0.680 |
CLV_PCSK_SKI1_1 | 72 | 76 | PF00082 | 0.308 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.534 |
DOC_USP7_MATH_1 | 109 | 113 | PF00917 | 0.617 |
DOC_USP7_MATH_1 | 115 | 119 | PF00917 | 0.552 |
DOC_USP7_UBL2_3 | 229 | 233 | PF12436 | 0.505 |
DOC_USP7_UBL2_3 | 237 | 241 | PF12436 | 0.496 |
DOC_WW_Pin1_4 | 79 | 84 | PF00397 | 0.666 |
LIG_14-3-3_CanoR_1 | 122 | 128 | PF00244 | 0.693 |
LIG_APCC_ABBA_1 | 74 | 79 | PF00400 | 0.524 |
LIG_BRCT_BRCA1_1 | 123 | 127 | PF00533 | 0.641 |
LIG_BRCT_BRCA1_1 | 241 | 245 | PF00533 | 0.520 |
LIG_FHA_1 | 30 | 36 | PF00498 | 0.457 |
LIG_FHA_1 | 55 | 61 | PF00498 | 0.537 |
LIG_FHA_2 | 188 | 194 | PF00498 | 0.568 |
LIG_LIR_Gen_1 | 242 | 251 | PF02991 | 0.502 |
LIG_LIR_Gen_1 | 58 | 66 | PF02991 | 0.457 |
LIG_LIR_Nem_3 | 242 | 248 | PF02991 | 0.525 |
LIG_LIR_Nem_3 | 58 | 64 | PF02991 | 0.457 |
LIG_MLH1_MIPbox_1 | 241 | 245 | PF16413 | 0.520 |
LIG_PCNA_yPIPBox_3 | 2 | 14 | PF02747 | 0.318 |
LIG_Pex14_2 | 205 | 209 | PF04695 | 0.499 |
LIG_SH2_NCK_1 | 128 | 132 | PF00017 | 0.619 |
LIG_SH2_SRC | 128 | 131 | PF00017 | 0.689 |
LIG_SH3_3 | 90 | 96 | PF00018 | 0.651 |
LIG_SUMO_SIM_par_1 | 28 | 36 | PF11976 | 0.463 |
MOD_CDK_SPxxK_3 | 79 | 86 | PF00069 | 0.636 |
MOD_CK1_1 | 118 | 124 | PF00069 | 0.750 |
MOD_CK1_1 | 159 | 165 | PF00069 | 0.537 |
MOD_CK1_1 | 25 | 31 | PF00069 | 0.496 |
MOD_CK2_1 | 10 | 16 | PF00069 | 0.524 |
MOD_CK2_1 | 220 | 226 | PF00069 | 0.537 |
MOD_Cter_Amidation | 140 | 143 | PF01082 | 0.534 |
MOD_Cter_Amidation | 44 | 47 | PF01082 | 0.324 |
MOD_GlcNHglycan | 111 | 114 | PF01048 | 0.624 |
MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.627 |
MOD_GlcNHglycan | 177 | 180 | PF01048 | 0.656 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.722 |
MOD_GSK3_1 | 240 | 247 | PF00069 | 0.575 |
MOD_GSK3_1 | 25 | 32 | PF00069 | 0.461 |
MOD_N-GLC_1 | 159 | 164 | PF02516 | 0.720 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.509 |
MOD_NEK2_1 | 244 | 249 | PF00069 | 0.539 |
MOD_NEK2_1 | 275 | 280 | PF00069 | 0.529 |
MOD_NEK2_1 | 77 | 82 | PF00069 | 0.576 |
MOD_NEK2_2 | 123 | 128 | PF00069 | 0.659 |
MOD_PK_1 | 22 | 28 | PF00069 | 0.408 |
MOD_PKA_1 | 220 | 226 | PF00069 | 0.485 |
MOD_PKA_2 | 121 | 127 | PF00069 | 0.775 |
MOD_PKA_2 | 66 | 72 | PF00069 | 0.468 |
MOD_PKA_2 | 77 | 83 | PF00069 | 0.523 |
MOD_Plk_1 | 239 | 245 | PF00069 | 0.655 |
MOD_Plk_1 | 29 | 35 | PF00069 | 0.524 |
MOD_Plk_1 | 72 | 78 | PF00069 | 0.496 |
MOD_Plk_2-3 | 240 | 246 | PF00069 | 0.573 |
MOD_Plk_4 | 240 | 246 | PF00069 | 0.576 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.490 |
MOD_ProDKin_1 | 79 | 85 | PF00069 | 0.667 |
MOD_SUMO_rev_2 | 15 | 23 | PF00179 | 0.408 |
MOD_SUMO_rev_2 | 187 | 197 | PF00179 | 0.610 |
MOD_SUMO_rev_2 | 216 | 223 | PF00179 | 0.471 |
MOD_SUMO_rev_2 | 226 | 234 | PF00179 | 0.478 |
MOD_SUMO_rev_2 | 69 | 74 | PF00179 | 0.508 |
TRG_ER_diArg_1 | 181 | 183 | PF00400 | 0.592 |
TRG_ER_diArg_1 | 282 | 284 | PF00400 | 0.563 |
TRG_ER_diArg_1 | 289 | 292 | PF00400 | 0.584 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCC4 | Leptomonas seymouri | 70% | 100% |
A0A1X0P4R0 | Trypanosomatidae | 47% | 100% |
A0A3Q8IGG5 | Leishmania donovani | 88% | 99% |
A4HEG4 | Leishmania braziliensis | 86% | 100% |
A4I195 | Leishmania infantum | 88% | 99% |
D0A5I6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
E9AXD1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
P45978 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 29% | 85% |
Q9BX40 | Homo sapiens | 31% | 77% |